Live Breaking News & Updates on Serum institute vaccine

Stay informed with the latest breaking news from Serum institute vaccine on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Serum institute vaccine and stay connected to the pulse of your community

Serum's Poonawalla to buy and rebrand Magma Fincorp; to hold 60% stake

Read more about Adar Poonawalla to acquire 60% in Magma Fincorp for Rs 3,456-crore on Business Standard. As a part of deal, Magma will get fresh capital of Rs 3,456 crore

Kerala , India , Sanjay-chamria , Adar-poonawalla , Abhay-bhutada , Sanjay-chamaria , Mayank-poddar , Rising-sun-holding , Axis-capital , Vinod-kothari-co , Khaitan-co , Serum-institute

Coronavirus: Pune court dismisses plea against Serum Institute's use of 'Covishield' as trademark

Nanded-based pharmaceutical products manufacturer Cutis Biotech had filed a civil lawsuit asking the company to stop using the name.

Nanded , Maharashtra , India , United-states , Pune , Aditya-soni , Hitesh-jain , Serum-institute-covishield , Astrazeneca , Serum-institute , Indian-council-of-medical-research , Oxford-university

Sharad Pawar visits Serum Institute in Pune, reviews situation after fire incident

NCP supremo Sharad Pawar on Saturday visited the Serum Institute of India (SII) in Pune, where a major fire had broken out two days ago. Five contractual labourers engaged in electrical work lost their lives due to the blaze.

India , Uddhav-thackeray , Serum-institute-of-india , Maharashtra-chief-minister-uddhav-thackeray , Aaditya-thackeray , Serum-institute , Sharad-pawar , Serum-institute-vaccine , Sharad-pawar-pune , Sharad-pawar-serum-institute , Serum-institute-fire , Adar-poonawalla

India to send gift of COVID vaccines to Sri Lanka next week

India to send gift of COVID vaccines to Sri Lanka next week
The island nation will get 500,000 doses of the "Made in India" Covishield vaccine on January 27.
Share
Updated: Jan 23, 2021, 05:55 PM IST
India will be sending a "gift" of COVID vaccines to Sri Lanka next week. Sri Lankan President Gotabaya Rajapaksa has announced, the vaccine will reach the country on January 27. The island nation will get 500,000 doses of the "Made in India" Covishield vaccine and it will become the eighth country to which India is gifting COVID vaccines since it began its country-wide mega immunisation programme on January 16.
Starting Wednesday, India has gifted vaccines to seven countries in the region as part of its 'neighbourhood-first' policy -- Bhutan (150,000), Maldives (100,000), Nepal (One million), Bangladesh (2 million), Myanmar (1.5 M), Seychelles (50,000) and Mauritius (100,000).

Mongolia , Bangladesh , Afghanistan , India , Seychelles , Colombo , Western , Sri-lanka , Maldives , Morocco , Nepal , Brazil

COVID-19 Vaccine Export May Start In 2 Weeks, Says Serum Institute CEO Adar Poonawalla

Serum Institute's Chief Executive Officer Adar Poonawalla said that exports of the COVID-19 vaccine doses will start only after local requirements are fully met.

India , United-states , United-kingdom , Adar-poonawalla , Astrazeneca , Serum-institute , Oxford-university , Serum-institute-of-india , Reuters , Business-standard , Chief-executive-officer , Prime-minister-narendra-modi

Stage set for roll-out of world's biggest vaccination drive against COVID on Saturday

A total of 3,006 session sites across all states and union territories will be virtually connected during the launch at 10.30 am by Prime Minister Narendra Modi and around 100 beneficiaries will be vaccinated at each session site.

Madhya-pradesh , India , New-delhi , Delhi , Dibrugarh , Assam , Gandhinagar , Gujarat , Ahmedabad , Barpeta , Bharat , Harsh-vardhan

COVID-19 vaccine | First batches of Covishield, Serum Institute's vaccine against COVID-19 leave Pune - Early visuals

Updated Jan 12, 2021 | 11:25 IST
Pooja was performed at the gates of Serum Institute of India as three temperature-controlled trucks left the facility of the institute.
First batches of COVID-19 vaccine leave from Serum Institute of India | Photo Credit: ANI
Key Highlights
The vaccine is being carried to different parts of the country via eight flights
Government has committed to purchase 4.6 crore Covishield doses from SII
Pune: Ahead of the vaccination drive against coronavirus, the first batches of Covishield, the vaccine produced by Serum Institute of India (SII) left Pune to be taken to different parts of the country. The first batch of the vaccine reached Delhi International Airport at about 10.40 am.

Delhi , India , Pune , Maharashtra , Sandip-bhosale , Namrata-patil , Pune-international-airport , Serum-institute-of-india , Serum-institute , Photo-credit , Delhi-airport , Covid-19-vaccine

Govt wants Serum Institute to lower price of AstraZeneca shot: Report

Govt wants Serum Institute to lower price of AstraZeneca shot: Report
Premium
(Photo: Mint)
Neha Arora,
, Reuters
Senior officials have been discussing the terms of the deal with the Serum Institute for weeks, hoping to bring down prices below $3 per shot
Share Via
Read Full Story
The Indian government has been negotiating with the Serum Institute of India to bring down the price of AstraZeneca's COVID-19 vaccine, people close to the matter said, delaying the roll-out of the country's immunisation programme.
India's drug regulator has approved emergency use of the vaccine developed by Oxford University as well as another developed by Indian firm Bharat Biotech, but the government has not placed firm orders with either firm.

India , Gandhigram , Rajasthan , Surat , Gujarat , Dehradun , Uttaranchal , Kothi , Maharashtra , Bardoli , Brazil , Beijing

Coronavirus: Serum Institute's Adar Poonawalla On Covishield Vaccine Approval: Happy New Year, All Risks Paid Off

Covishield is ready for "roll-out in the coming weeks", said Adar Poonawalla. (File photo)
New Delhi:
All the risks taken by Serum Institute have finally paid off, tweeted Adar Poonawalla, the chief executive of the Pune-based vaccine manufacturer, shortly after the country's drug regulator cleared its Covishield vaccine for emergency approval in India. Mr Poonawalla reiterated that the Covishield vaccine -- developed by Serum Institute of India in partnership with the Oxford University and pharma major AstraZeneca - is "safe and effective" against coronavirus and added that the vaccine "is ready to roll out in the coming weeks".
Mr Poonawalla, CEO of the Serum Institute, said to be the world's largest vaccine maker, had earlier said the "majority of the first 50 million doses will go to India".

United-states , India , United-kingdom , Pune , Maharashtra , American , Narendra-modi , Adar-poonawalla , Aatmanirbhar-bharat , Zikk-adar-poonawalla , Pfizer , Astrazeneca

Delhi: Nine lakh health and frontline workers to get coronavirus vaccine in first phase

File photo of Delhi Health Minister Satyendar Jain.
|
HT Photo
Delhi Health Minister Satyendar Jain on Sunday said that three lakh healthcare workers and six lakh frontline workers will be vaccinated in the first phase of the immunisation process against coronavirus in the national Capital, ANI reported. People above the age of 50 will be next in line for the vaccine, Jain said, according to NDTV.
“The preparations for the rollout is underway in Delhi,” the health minister said. “A storage facility has been created. We are preparing to set up 1,000 centers. We are setting up around 500 to 600 centers for the first phase. We will start administering the vaccine as soon as it is made available.”

Hindustan , India-general , India , Delhi , Bharat , Balbir-singh-sidhu , National-institute-of-virology , Delhi-health , Indian-council-of-medical-research , Punjab-health , Astrazeneca , Serum-institute